Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Aya El Helali"'
Autor:
Wei Kang, Caige Huang, Vincent K. C. Yan, Yue Wei, Jessica J. P. Shami, Silvia T. H. Li, Yu Yang, Xuxiao Ye, Junhan Tang, Shing Fung Lee, Victor H. F. Lee, Stephen L. Chan, Aya El Helali, Ka On Lam, Roger K. C. Ngan, Ian C. K. Wong, Esther W. Chan
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-11 (2024)
Abstract Given the existing uncertainty regarding the effectiveness and safety of switching from low-molecular-weight heparin (LMWH) to direct oral anticoagulants (DOACs) in patients with cancer-associated venous thrombosis (CAT), we conducted a comp
Externí odkaz:
https://doaj.org/article/3266406845e141328a147fcdb5358cb5
Publikováno v:
Cancer Medicine, Vol 12, Iss 24, Pp 22316-22324 (2023)
Abstract Background Despite the growth in primary cancer (PC) survivors, the trends and disparities in this population have yet to be comprehensively examined using competing risk analysis. The objective is to examine trends in time to second primary
Externí odkaz:
https://doaj.org/article/c00128d2d9124da994c69c82bdddb122
Autor:
Chi Leung Chiang, Tai Chung Lam, James Chun Bong Li, Kenneth Sik Kwan Chan, Aya El Helali, Yolanda Yim Ping Lee, Laalaa Hiu Ting Law, Danyang Zheng, Anthony Wing Ip Lo, Ngar Woon Kam, Wing Sum Li, Alice Ka Wai Cheung, James Chung Hang Chow, Sunny Po Chung Chan, Jessica Wing Yu Lai, Sarah Wai Man Lee, Feng-Ming (Spring) Kong, Wai Tong Ng, Dora Lai Wan Kwong, Anne Wing Mui Lee
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 40, Iss , Pp 100898- (2023)
Summary: Background: The strategy of dual blockade of TGF-β and PD-L1 pathways has not been previously tested in platinum-refractory recurrent or metastatic nasopharyngeal cancer (R/M NPC) patients. This study aimed to evaluate the safety and effica
Externí odkaz:
https://doaj.org/article/8a4c0f1c23f14e66b633df5f0add5a87
Autor:
Yik‐Laam Hung, Siu‐Sing Leung, Siu‐Ting Pamela Chiu, Pik‐Yi Li, Anson Chi‐On Kan, Chi‐Chung Lo, Sze‐Yuen Zeta Wong, Sze‐Lam Luk, Cheuk‐Lam Charlotte Lai, Aya El Helali, Wendy Wing‐Lok Chan
Publikováno v:
Cancer Medicine, Vol 12, Iss 2, Pp 1997-2007 (2023)
Abstract Introduction An increasing number of breast cancer survivors (BCS) use traditional Chinese medicine (TCM) throughout their cancer journey. There is emerging evidence that TCM is effective in the reducing side effects of chemotherapy. However
Externí odkaz:
https://doaj.org/article/5cd1dd0e6aae4fa6be6403837a2dd772
Autor:
Wei Kang, Kuan Peng, Vincent K.C. Yan, Daoud Al-Badriyeh, Shing Fung Lee, Hei Hang Edmund Yiu, Yue Wei, Silvia T. H. Li, Xuxiao Ye, Aya El Helali, Ka On Lam, Victor H. F. Lee, Ian C. K. Wong, Esther W. Chan
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 17, Iss 1 (2024)
Background Direct oral anticoagulants (DOACs) have demonstrated clinical benefits and better patient adherence over low-molecular-weight heparin (LMWH) in treating patients with cancer-associated venous thrombosis (CAT). We aimed to compare the cost-
Externí odkaz:
https://doaj.org/article/fc12840ea12043cfa1e40c07e93c83c3
Autor:
Aya El Helali, Charlene H. L. Wong, Horace C. W. Choi, Wendy W. L. Chan, Naomi Dickson, Steven W. K. Siu, Karen K. Chan, Hextan Y. S. Ngan, Roger K. C. Ngan, Richard D. Kennedy
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-17 (2022)
Abstract The efficacy of anti-angiogenic agents (AAAs) in epithelial ovarian cancer (EOC) remains unclear. Therefore, we conducted a systematic review and network meta-analysis (NMA) to synthesize evidence of their comparative effectiveness for impro
Externí odkaz:
https://doaj.org/article/62538a26db794afc8b0ffb64fb45f774
Autor:
Aya El Helali, Jun Tao, Charlene H. L. Wong, Wendy Wing-Lok Chan, Ka-Chun Mok, Wing Fong Wu, Kohei Shitara, Markus Mohler, Narikazu Boku, Herbert Pang, Ka On Lam
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundWhile the efficacy of immune checkpoint inhibitors (ICIs) is increasingly recognized in advanced gastric cancer (aGC), overall survival (OS) has not been consistently improved across the different randomized controlled trials (RCTs). This m
Externí odkaz:
https://doaj.org/article/c1baf14ea5aa46459a32b39d638e033e
Autor:
Zhiyuan Xu, Li Yang, Wai-Tong Ng, Aya El Helali, Victor Ho-Fun Lee, Lingyu Ma, Qin Liu, Jishi Li, Lin Shen, Jijie Huang, Jiandong Zha, Cheng Zhou, Anne W. M. Lee, Longhua Chen
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundWe conducted this study to evaluate if a reduced cumulative dose of induction and concurrent cisplatin conferred similar favorable outcomes when compared to trial NPC-0501.MethodsNewly diagnosed nasopharyngeal carcinoma (NPC) with stage III
Externí odkaz:
https://doaj.org/article/7f22d18e4520460f9f9ee47e913589c4
Publikováno v:
Hong Kong Medical Journal. 28:396-399
Autor:
Peter Y M Woo, Stephen Yau, Tai-Chung Lam, Jenny K S Pu, Lai-Fung Li, Louisa C Y Lui, Danny T M Chan, Herbert H F Loong, Michael W Y Lee, Rebecca Yeung, Carol C H Kwok, Siu-Kie Au, Tze-Ching Tan, Amanda N C Kan, Tony K T Chan, Calvin H K Mak, Henry K F Mak, Jason M K Ho, Ka-Man Cheung, Teresa P K Tse, Sarah S N Lau, Joyce S W Chow, Aya El-Helali, Ho-Keung Ng, Wai-Sang Poon
Publikováno v:
Neuro-Oncology Practice. 10:50-61
Background The aim of this study is to address the paucity of epidemiological data regarding the characteristics, treatment patterns and survival outcomes of Chinese glioblastoma patients. Methods This was a population-level study of Hong Kong adult